Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is good evidence that abnormal calcium accumulation may be a final common pathway of muscle degeneration in the muscular dystrophies. Prostaglandins are able to promote calcium entry into cells and excess prostaglandin activity coupled with a defect in intracellular calcium release could cause toxic accumulations of calcium in intracellular organelles such as mitochondria.
Serotonin
stimulates prostaglandin synthesis while tricyclic antidepressants inhibit calcium release from intracellular organelles thus possibly accounting for the models of
muscular dystrophy
reported using this combination. The prostaglandin/calcium hypothesis can account for the effects of vitamin E, steroids and local anaesthetic-like drugs in
muscular dystrophy
. Since many drugs already in clinical use for other purposes can be used to control prostaglandin synthesis or action this hypothesis has immediate potential clinical applications.
...
PMID:The roles of prostaglandins and calcium accumulation in muscular dystrophy. 89 91
Serotonin
(
5-HT
) uptake was studied in the blood platelets of 10 patients with Duchenne-type
muscular dystrophy
(DMD) and 7 age-matched controls. Vmax (maximum number of uptake sites) of platelet
5-HT
uptake in the DMD patients was significantly less than that of the normal controls. There was no difference in the affinity for
5-HT
(Km) between the two groups. There was a significant negative correlation between serum creatine kinase activity and Km of
5-HT
uptake in blood platelets of these patients. However, no correlation was found between Km or Vmax and ambulatory status of DMD.
...
PMID:Serotonin uptake in blood platelets of Duchenne muscular dystrophy patients. 358 71
Injection of serotonin (5-hydroxytryptamine) induced a marked decrease in the level of glucose 1,6-diphosphate (Glc-1,6-P2) in the rat tibialis anterior muscle. Concomitant to the decrease in Glc-1,6-P2, the potent activator of phosphofructokinase and phosphoglucomutase, the activities of both these enzymes were markedly reduced by serotonin. The level of Glc-1,6-P2 and the activities of phosphofructokinase and phosphoglucomutase increased with age in the tibialis anterior muscle and the effect of serotonin was more pronounced in the older animals.
Serotonin
also induced a significant increase in the level of cyclic GMP in muscle. The serotonin-induced changes in the normal muscle mimic the changes in carbohydrate metabolism we found previously in
muscular dystrophy
.
...
PMID:Changes in the levels of glucose 1,6-diphosphate and cyclic GMP, and in the activities of phosphofructokinase and phosphoglucomutase induced by serotonin in muscle. 630 80